Luca Malorni
0000-0002-4297-2997
Publication & Citation Trends
Most Cited Works
Publications
243 total
Abstract PS2-07-13: Prognostic and predictive role of RBsig and CCNE1/RB1 gene-expression signatures for patients with early breast cancer treated with endocrine therapy with or without palbociclib in the PALLAS trial (ABCSG-42, AFT-05, BIG 14-03)
Cited by 0
Semantic Scholar
Overcoming Resistance to CDK4/6 inhibitors in Hormone Receptor positive, HER2 negative breast cancer: Innovative Combinations and Emerging Strategies.
Cited by 12
Semantic Scholar
504P Temporal dynamics of ESR1 mutations (ESR1m) and AKT pathway (AKTp) co-alterations at first-line (1L) progression in HR+ HER2- metastatic breast cancer: Defining optimal diagnostic windows
Cited by 0
Semantic Scholar
492P Single-molecule longitudinal cfDNA profiling reveals epigenetic modifications at progression on CDK4/6 inhibitors in advanced breast cancer
Cited by 0
Semantic Scholar
Efficacy and safety of systemic therapies following progression on CDK4/6 inhibitors in patients with HR+/HER2− metastatic breast cancer: a systematic review and network meta-analysis
Cited by 3
Semantic Scholar
774P Clinical and molecular profiling of high-risk localized colorectal cancer (CRC) in the LIBIMET trial
Cited by 1
Semantic Scholar
Palbociclib plus letrozole versus weekly paclitaxel, both in combination with trastuzumab plus pertuzumab, as neoadjuvant treatment for patients with HR+/HER2+ early breast cancer: primary results from the randomized phase II TOUCH trial (IBCSG 55-17).
Cited by 1
Semantic Scholar
52P Dynamics of ctDNA and serum thymidine kinase activity in patients with ER+/HER2- metastatic breast cancer receiving abemaciclib vs palbociclib or ribociclib: Early results of the TIRESIAS trial
Cited by 1
Semantic Scholar
Research Topics
Advanced Breast Cancer Therapies
(142)
Breast Cancer Treatment Studies
(60)
HER2/EGFR in Cancer Research
(60)
Cancer-related Molecular Pathways
(54)
Estrogen and related hormone effects
(47)
Frequent Co-Authors
Affiliations
Brigham and Women's Hospital
Translational Research Institute
Harvard University
Baylor College of Medicine
GTx (United States)